The PCI was successful, but now what?
Assess your patient’s risk for sudden cardiac death
CHAIRPERSONS
Prof. Dr. Eric Eeckhout
Lausanne, Switzerland
Prof. Dr. Michael Block
Munich/Germany
PANELISTS
Dr. Joern Schmitt
Giessen, Germany
PD Dr. Martin Arnold
Erlangen, Germany
Prof. Dr. Ernst Vester
Duesseldorf, Germany
Wednesday
20th May, 2015
13:35 – 14:35
Room 352 B
Pos
Risk As t-PCI
sessme
nt
 EF
≤ 35%
 TIM
I Flow 0
–2
 Age
> 65
 Mu
lti Vesse
l Diseas
 Ane
e
mia
 Ren
al Insuffi
ciency
 Killi
p Class
I or II
 Pre
vious M
I
 Typ
e 2 Diab
etes
 Hyp
ertensio
n
www.zoll.com/EuroPCRParis2015
During this session, discussion will include:
• The risk of sudden cardiac death in low ejection fraction, acute
myocardial infarction patients undergoing PCI/percutaneous
transluminal coronary angioplasty, including clinical evidence.
• The role of interventional cardiologists to screen
patients for sudden cardiac death risk and establish an
appropriate care path, including optimal medical therapy
and consideration of wearable cardioverter defibrillators, while
long-term sudden cardiac death risk is determined.
PROGRAM TIMELINE
MINUTES
PRESENTER
OBJECTIVE
Prof. Dr. Michael Block
Munich, Germany
Session objectives
15
Prof. Dr. Ernst Vester
Duesseldorf, Germany
Sudden cardiac death risk in the low
ejection fraction, acute myocardial
infarction patients undergoing PCI/
percutaneous transluminal coronary
angioplasty
15
Dr. Joern Schmitt
Giessen, Germany
Sudden cardiac death screening:
systematic techniques
10
PD Dr. Martin Arnold
Erlangen, Germany
Case examples – Wearable cardioverter
defibrillator use to protect patients
10
All Faculty
Discussion and audience interaction
Prof. Dr. Eric Eeckhout
Lausanne, Switzerland
Session evaluation and key learnings
5
5
©2015 ZOLL Medical Corporation. ZOLL and LifeVest are registered trademarks
of ZOLL Medical Corporation in the United States and/or other countries.
20C0457 Rev FI